Get the Stockscreener App
11.43
2.88%
0.32
After Hours:
11.15
-0.28
-2.45%
Yd Bio Ltd stock is traded at $11.43, with a volume of 155.23K.
It is up +2.88% in the last 24 hours and down -41.29% over the past month.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
See More
Previous Close:
$11.11
Open:
$11.2
24h Volume:
155.23K
Relative Volume:
2.35
Market Cap:
$803.73M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-33.51%
1M Performance:
-41.29%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$11.18
$13.99
1-Week Range:
$10.50
$17.99
52-Week Range:
$10.50
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
11.43 | 783.49M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Yd Bio Ltd Stock (YDES) Latest News
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES - The Manila Times
GYMD Showcases Industrial AI and Digitalization Strength at Tech Week Singapore 2025 - The Manila Times
20‑Year Exclusive Licenses — YD Bio Lists as YDES on Nasdaq to Scale cfDNA cancer tests and eye therapies - Stock Titan
YD Bio Limited (YDESW) Stock Price, News, Quote & History - Yahoo
YD Bio Ltd (YDES) latest press releases and corporate news - Yahoo
YD Bio Ltd (YDES) cash flow - Yahoo
YD Bio Ltd (YDES) Valuation Measures & Financial Statistics - Yahoo
Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities - Yahoo Finance
CAP Accreditation Secured: YD Bio partner EG BioMed's CLIA lab in Bothell bolsters U.S. cancer testing capabilities - Stock Titan
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results - BioSpace
MARTEN TRANSPORT CLOSES ON THE SALE OF ASSETS RELATED TO INTERMODAL BUSINESS - The Manila Times
Hub Group Closes on the Acquisition of Marten Transport Intermodal - The Manila Times
$13.2M Funding Boost: YD Bio Advances DNA Methylation Cancer Tests and Eye Therapies Pipeline - Stock Titan
Three Small-Caps Took Off On News And Fresh Deals - Finimize
YD Bio announces COO resignation and updates on public warrant registration By Investing.com - Investing.com Nigeria
YD Bio announces COO resignation and updates on public warrant registration - Investing.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market SessionApellis Pharmaceuticals (NASDAQ:APLS), Concentrix (NASDAQ:CNXC) - Benzinga
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
Xinhua Finance: Chongqing’s Intelligent Bionic Robot Competition Highlights Advances in “Evolving” Robotics - digitalmore.co
New Mountain Finance, Texas Instruments, Analog… - inkl
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket - Benzinga
We're Keeping An Eye On YD Bio's (NASDAQ:YDES) Cash Burn Rate - 富途牛牛
YD Bio Limited (YDESW) stock price, news, quote and history - Yahoo
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - inkl
Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month - simplywall.st
Why Did YD Bio Plunge 14.37% Despite Revenue Growth? - AInvest
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
YD Bio Limited shares rise 7.33% premarket after being added to NASDAQ. - AInvest
Yd Bio Limited shares rise 56.25% intraday after being added to NASDAQ. - AInvest
Diabetic Macular Edema Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotech Novartis - The Globe and Mail
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal - Asianet Newsable
YD Bio Limited Announces Closing of Business Combination - citybiz
symbol__ Stock Quote Price and Forecast - CNN
YDES Stock Price and Chart — NASDAQ:YDES - TradingView
YDESBreeze Holdings Latest Stock News & Market Updates - Stock Titan
YD Bio's Nasdaq Debut: A Strategic SPAC Merger Positions the Biotech Innovator for High-Growth Catalysts - AInvest
Nasdaq: YD Bio Completes Merger With Breeze - AInvest
YD Bio Shares to Begin Trading on Nasdaq After Completing Merger With Breeze - MarketScreener
YD Bio Limited begins trading on Nasdaq under YDES, YDESW symbols. - AInvest
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market - PR Newswire
YD Bio Ltd (YDES) stock price, news, quote and history - Yahoo
YD Bio Ltd (YDES) Stock Price, News, Quote & History - Yahoo
Yd Bio Ltd Stock (YDES) Financials Data
There is no financial data for Yd Bio Ltd (YDES). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):